Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NY:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about
< Previous
1
2
...
37
38
39
40
41
42
43
44
Next >
El Nino Ventures Inc. expands drill program to 7,000 meters using a second drill rig in the Democratic Republic of Congo
October 25, 2007
TSX.V: ELN OTCBB: ELNOF Frankfurt: E7Q
From
PR Newswire
Elan Reports Third Quarter 2007 Financial Results
October 24, 2007
From
Business Wire News Releases
El Nino Ventures Acquires Significant Land Position in Ireland
October 17, 2007
TSX.V: ELN OTCBB: ELNOF Frankfurt: E7Q
From
PR Newswire
Wall Street News Alert: Hot Stocks to Watch: ERUC! October 16, 2007
October 16, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
From
Marketwired News Releases
Elan Update
October 14, 2007
From
Business Wire News Releases
Elan and Biogen Idec Announce That FDA Will Extend Regulatory Review Period for TYSABRI(R) for Crohn's Disease
October 14, 2007
From
Business Wire News Releases
New TYSABRI(R) Data to Be Presented at the European Committee for Treatment and Research in Multiple Sclerosis
October 11, 2007
Study Shows Increased Proportion of Patients Achieve Disease-Free Status with TYSABRI Separate Study Demonstrates Plasma Exchange May Be an Effective Tool to Accelerate TYSABRI Removal
From
Business Wire News Releases
Biogen Idec and Elan Provide Update on Utilization and Safety of TYSABRI(R) in Patients with Multiple Sclerosis
October 11, 2007
From
Business Wire News Releases
El Nino Ventures Inc. 5,000 meter drilling program in the Democratic Republic of Congo (DRC) is underway
October 09, 2007
------------------------------------------------------------------------- - Drilling has started on the DRC properties. - Airborne geophysics survey is completed. - Presently negotiating acquisition of...
From
PR Newswire
Elan Announces Webcast of Third Quarter 2007 Financial Results
October 08, 2007
From
Business Wire News Releases
El Nino Ventures Identifies New Copper Mineralized Zone on Properties in the Democratic Republic of Congo (DRC)
September 20, 2007
TSX.V: ELN OTCBB: ELNOF FRANKFURT: E7Q
From
PR Newswire
El Nino Ventures & Xstrata Zinc 25,000 m Drill Program in Progress in the Bathurst Mining Camp
September 19, 2007
- $5.0M Exploration Program on the Bathurst Project is in progress
From
PR Newswire
Elan Announces New Board of Director Members
September 13, 2007
From
Business Wire News Releases
Transition Therapeutics Announces Completion of Phase I Clinical Studies with Alzheimer's Disease Drug Candidate ELND-005/AZD-103
August 29, 2007
From
PR Newswire
Michael J. Fox Foundation and New York Academy of Sciences to Host First Major Parkinson's Drug Development Conference
August 21, 2007
From
Business Wire News Releases
El Nino Ventures Inc to start 5,000 meter drill program on their Democratic Republic of Congo (DRC) Properties
August 20, 2007
From
PR Newswire
TYSABRI(R) Demonstrates Significant Health-Related Quality-of-Life Improvements for Multiple Sclerosis Patients in Study Published in Annals of Neurology
August 19, 2007
From
Business Wire News Releases
Dr. Lars Ekman, President of Research and Development, Transitions to Board of Director Role
August 08, 2007
From
Business Wire News Releases
The Michael J. Fox Foundation for Parkinson's Research Announces $1.2 Million in Funding to Advance Development of Drug Targets for PD
August 01, 2007
From
PR Newswire
SmallCap Sentinel: Baby Boomers and Biotech Breakthroughs
August 01, 2007
From
GlobeNewswire News Releases
Joint FDA Advisory Committee Recommends Approval of TYSABRI(R) for the Treatment of Moderate to Severe Crohn's Disease
July 31, 2007
From
Business Wire News Releases
Wall Street News Alert: Aggressive Stock Alert: GPMIJ! July 31, 2007
July 31, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
From
Marketwired News Releases
Elan Reports Second Quarter 2007 Financial Results
July 25, 2007
From
Business Wire News Releases
Alzheimer's Drug Discovery Foundation Invites Scientists to Apply for Grant Award Program
July 24, 2007
From
Marketwired News Releases
TYSABRI(R) Celebrates One-Year Anniversary as a Treatment for Multiple Sclerosis
July 22, 2007
As of Mid-July, Approximately 14,000 Patients on Therapy Worldwide
From
Business Wire News Releases
Elan and Biogen Idec Preparing to Appeal Ruling on European Application for Natalizumab for the Treatment of Crohn's Disease
July 19, 2007
From
Business Wire News Releases
Elan Announces Webcast of Second Quarter 2007 Financial Results
July 09, 2007
From
Business Wire News Releases
TYSABRI(R) Recommended by NICE for Use in Highly Active Relapsing Remitting Multiple Sclerosis in the Final Appraisal Determination
July 02, 2007
New Hope For People With Highly Active Multiple Sclerosis
From
Business Wire News Releases
Peplin Appoints Chief Commercial Officer
May 29, 2007
From
Business Wire News Releases
Elan and Biogen Idec Announce a FDA Advisory Committee Meeting to Review TYSABRI(R) for the Treatment of Crohn's Disease
May 28, 2007
From
Business Wire News Releases
< Previous
1
2
...
37
38
39
40
41
42
43
44
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.